Noninvasive prenatal testing in the general obstetric population: Clinical performance and counseling considerations in over 85000 cases

Prenatal Diagnosis

Volumn 36, Issue 3, 2016, Pages 237-243

  Taneja, Patricia A ^a   Snyder, Holly L ^a   de Feo, Eileen ^a   Kruglyak, Kristina M ^a   Halks Miller, Meredith ^a   Curnow, Kirsten J ^a   Bhatt, Sucheta ^a  

^a ILLUMINA INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANEUPLOIDY; ARTICLE; CHROMOSOME 13; CHROMOSOME 18; CHROMOSOME 21; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; NON INVASIVE PROCEDURE; PATIENT COUNSELING; PATIENT INFORMATION; PREDICTIVE VALUE; PREGNANCY; PRENATAL SCREENING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRISOMY 13; TRISOMY 18; TRISOMY 21; TURNAROUND TIME; ADOLESCENT; COUNSELING; EPIDEMIOLOGY; GENETIC SCREENING; MIDDLE AGED; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; PROCEDURES; STANDARDS; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; ANEUPLOIDY; COUNSELING; FEMALE; GENETIC TESTING; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84960081693     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4766     Document Type: Article

References (29)

1. Norton ME, Brar H, Weiss J, et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;207(2):137.e1-8.
2. Palomaki GE, Deciu C, Kloza EM, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 2012;14(3):296-305.
3. Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011;13(11):913-20.
4. Bianchi DW, Platt LD, Goldberg JD, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012;119(5):890-901.
5. Devers PL, Cronister A, Ormond KE, et al. Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors. J Genet Couns 2013;22(3):291-95.
6. Gregg AR, Gross SJ, Best RG, et al. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet Med 2013;15(5):395-98.
7. Soothill PW, Lo YMD. Scientific Impact Paper No. 15: non-invasive prenatal testing for chromosomal abnormality using maternal plasma DNA. Royal Coll Obstet Gynaecol 2014;1-14.
8. Committee Opinion No. 640. Cell-free DNA screening for fetal aneuploidy. Obstet Gynecol 2015;126(3):e31-e7.
9. Benn P, Borrell A, Chiu RW, et al. Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn 2015;35(8):725-34.
10. Futch T, Spinosa J, Bhatt S, et al. Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples. Prenat Diagn 2013;33(6):569-74.
11. Bianchi DW, Parsa S, Bhatt S, et al. Fetal sex chromosome testing by maternal plasma DNA sequencing: clinical laboratory experience and biology. Obstet Gynecol 2015;125(2):375-82.
12. Dar P, Curnow KJ, Gross SJ, et al. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based non-invasive prenatal aneuploidy testing. Am J Obstet Gynecol 2014;211(5):527.e1-17.
13. McCullough RM, Almasri EA, Guan X, et al. Non-invasive prenatal chromosomal aneuploidy testing-clinical experience: 100, 000 clinical samples. PLoS One 2014;9(10):e109173.
14. Beamon CJ, Hardisty EE, Harris SC, et al. A single center's experience with noninvasive prenatal testing. Genet Med 2014;16(9):681-87.
15. Fairbrother G, Johnson S, Musci TJ, et al. Clinical experience of noninvasive prenatal testing with cell-free DNA for fetal trisomies 21, 18, and 13, in a general screening population. Prenat Diagn 2013;33(6):580-83.
16. Wang JC, Sahoo T, Schonberg S, et al. Discordant noninvasive prenatal testing and cytogenetic results: a study of 109 consecutive cases. Genet Med 2014;17(3):234-36.
17. Willems PJ, Dierickx H, Vandenakker E, et al. The first 3, 000 non-invasive prenatal tests (NIPT) with the harmony test in Belgium and the Netherlands. Facts Views Vis Obgyn 2014;6(1):7-12.
18. Wax JR, Cartin A, Chard R, et al. Noninvasive prenatal testing: impact on genetic counseling, invasive prenatal diagnosis, and trisomy 21 detection. J Clin Ultrasound 2015;43(1):1-6.
19. National Society of Genetic Counselors. Abnormal non-invasive prenatal testing results: what do they mean? 2015. Available at: http://nsgc.org/page/abnormal-non-invasive-prenatal-testing-results [accessed on 25 February 2015].
20. Gardner RJM, Sutherland GR, Shaffer LG. Parental age counseling and screening for fetal trisomy. In Chromosome abnormalities and genetic counseling, 4th ed. New York, NY: Oxford University Press; 2012. p 403-16.
21. Curnow KJ, Wilkins-Haug L, Ryan A, et al. Detection of triploid, molar, and vanishing twin pregnancies by a single-nucleotide polymorphism-based noninvasive prenatal test. Am J Obstet Gynecol 2015;212(1):79 e1-9.
22. American College of Obstetricians and Gynecologists. Committee Opinion No. 545: noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol 2012;120(6):1532-34.
23. Pergament E, Cuckle H, Zimmermann B, et al. Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort. Obstet Gynecol 2014;124(2 Pt 1):210-18.
24. Norton ME, Jacobsson B, Swamy GK, et al. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med 2015. DOI:10.1056/NEJMoa1407349.
25. Bianchi DW, Parker RL, Wentworth J, et al. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 2014;370(9):799-808.
26. Grati FR, Malvestiti F, Ferreira JC, et al. Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. Genet Med 2014;16(8):620-24.
27. Society for Maternal Fetal Medicine. Cell free DNA screening is not a simple blood test 2014. Available at: https://www.smfm.org/publications/183-cell-free-dna-screening-is-not-a-simple-blood-test [accessed on 25 February 2015].
28. Benn P, Borell A, Chiu R, et al. Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn 2013;33(7):622-29.
29. Benn P, Borrell A, Cuckle H, et al. Prenatal detection of Down syndrome using massively parallel sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011. Prenat Diagn 2012;32(1):1-2.